Brokers Issue Forecasts for Owens & Minor, Inc.’s FY2027 Earnings (NYSE:OMI)

Owens & Minor, Inc. (NYSE:OMIFree Report) – Investment analysts at Leerink Partnrs issued their FY2027 earnings per share (EPS) estimates for Owens & Minor in a research note issued on Monday, August 5th. Leerink Partnrs analyst M. Cherny expects that the company will post earnings of $2.62 per share for the year. The consensus estimate for Owens & Minor’s current full-year earnings is $1.54 per share.

OMI has been the topic of a number of other research reports. Barclays cut their target price on Owens & Minor from $23.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Monday. Citigroup upgraded Owens & Minor from a “neutral” rating to a “buy” rating and reduced their price objective for the company from $24.00 to $19.00 in a research note on Friday, July 19th. Bank of America decreased their price objective on Owens & Minor from $18.00 to $16.00 and set an “underperform” rating for the company in a report on Tuesday, June 25th. StockNews.com cut shares of Owens & Minor from a “buy” rating to a “hold” rating in a report on Friday. Finally, Robert W. Baird decreased their price target on shares of Owens & Minor from $20.00 to $19.00 and set a “neutral” rating for the company in a research note on Tuesday, July 16th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $20.14.

View Our Latest Stock Analysis on OMI

Owens & Minor Price Performance

Shares of OMI opened at $15.31 on Wednesday. The company has a debt-to-equity ratio of 2.17, a current ratio of 1.16 and a quick ratio of 0.56. Owens & Minor has a 1-year low of $12.36 and a 1-year high of $28.35. The stock has a market cap of $1.17 billion, a PE ratio of -30.02, a price-to-earnings-growth ratio of 0.52 and a beta of 0.25. The firm has a fifty day moving average price of $15.41 and a 200 day moving average price of $20.16.

Owens & Minor (NYSE:OMIGet Free Report) last issued its quarterly earnings data on Friday, August 2nd. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.33 by $0.03. Owens & Minor had a negative net margin of 0.37% and a positive return on equity of 12.97%. The business had revenue of $2.67 billion during the quarter, compared to the consensus estimate of $2.65 billion. During the same quarter in the previous year, the firm earned $0.18 EPS. The company’s revenue was up 4.2% compared to the same quarter last year.

Insider Activity at Owens & Minor

In other news, EVP Heath H. Galloway sold 2,031 shares of the firm’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $20.18, for a total value of $40,985.58. Following the completion of the sale, the executive vice president now owns 56,898 shares in the company, valued at approximately $1,148,201.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, EVP Snehashish Sarkar sold 9,980 shares of Owens & Minor stock in a transaction that occurred on Tuesday, June 4th. The stock was sold at an average price of $17.32, for a total value of $172,853.60. Following the sale, the executive vice president now directly owns 59,137 shares in the company, valued at $1,024,252.84. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Heath H. Galloway sold 2,031 shares of the company’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $20.18, for a total value of $40,985.58. Following the transaction, the executive vice president now directly owns 56,898 shares in the company, valued at approximately $1,148,201.64. The disclosure for this sale can be found here. Insiders have sold a total of 31,923 shares of company stock worth $562,711 in the last three months. Insiders own 3.59% of the company’s stock.

Institutional Investors Weigh In On Owens & Minor

A number of hedge funds and other institutional investors have recently bought and sold shares of OMI. Campbell & CO Investment Adviser LLC purchased a new position in shares of Owens & Minor in the 4th quarter valued at about $852,000. Vanguard Group Inc. increased its holdings in Owens & Minor by 1.9% in the first quarter. Vanguard Group Inc. now owns 8,749,866 shares of the company’s stock valued at $242,459,000 after buying an additional 162,182 shares in the last quarter. First Eagle Investment Management LLC lifted its position in shares of Owens & Minor by 39.7% during the 4th quarter. First Eagle Investment Management LLC now owns 241,534 shares of the company’s stock valued at $4,654,000 after acquiring an additional 68,596 shares during the period. Norges Bank purchased a new stake in shares of Owens & Minor during the 4th quarter worth approximately $9,160,000. Finally, Gabelli Funds LLC grew its holdings in shares of Owens & Minor by 25.9% in the 1st quarter. Gabelli Funds LLC now owns 170,000 shares of the company’s stock worth $4,711,000 after acquiring an additional 35,000 shares during the period. Institutional investors and hedge funds own 98.04% of the company’s stock.

About Owens & Minor

(Get Free Report)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Featured Stories

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.